Revium Rx. cotiza a 1.43 USD y tiene una capitalización bursátil de $87M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors; specializes in infectious diseases, including antib…
| Métrica | RVRC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -195.4% | -40.4% | -155.0% |
| ROA | -162.1% | -32.0% | -130.1% |
| Current Ratio | 2.26 | 2.84 | -0.58 |
| Debt / Equity | — | 0.28 | — |